Royal Ancient Oats™ Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorStandard Process Inc.
About this trial
Evaluating the effects of high avenanthramide ancient oat (Royal Ancient Oats™) muffins versus conventional oat muffins in regard to glycemic control.
Eligibility criteria
Qualifiers
Non-diabetic (HbA1c<5.7%) adults both men and women between the ages of 35-65 years with body mass index (BMI) ranging from 25 to 30 kg/m2
Participants who meet the inclusion criteria will be screened prior to starting the study and must be able to adhere to the requirements of the study.
Willing to comply with study procedures and supplement regimens.
Providing consent to participate in the study.
Disqualifiers
Participants who have experienced weight loss or gain exceeding 5% of their body weight in the past 3 months, including those involved in any weight loss or weight gain programs through diet and/or lifestyle changes.
Participants currently taking medications that could alter metabolism, such as weight loss medications, anti-hypertensive drugs, or lipid-lowering medications.
Participants with any chronic metabolic diseases, including diabetes, or those using supplements other than a daily multivitamin.
Pregnant or lactating women will be excluded from the study.
Trial design
Treatments tested in this trial
- Royal Ancient Oat Flour™
Treatment groups
38 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov